Breast-conserving surgery could be performed in patients with early-stage MBC; however, it is reported that modified radical mastectomy is often the preferred option for definitive surgical intervention due to larger tumor size, higher tumor grade, and hormone receptor negativity compared with IDC [28,29,30]. The gene discussed is NR4A1; the disease is neoplasm.